SAGE Therapeutics Inc. (SAGE) Vaulted To A New High On Study Results

SAGE Therapeutics Inc. (SAGE) announced Thursday morning that its Phase 2 study of SAGE-217 showed a statistically significant mean reduction in the Hamilton Rating Scale for Depression.

from RTT - Before the Bell http://ift.tt/2BPldnD
via IFTTT